Target intelligence / Profile preview

Synthetic Opioids

Molecular classification
Other
01

Overview

Synthetic opioids" is not a molecule or receptor but a **class of substances** synthesized in laboratories that act on opioid receptors in the brain and body, producing analgesic and euphoric effects[7][6]. Well-known examples include fentanyl, methadone, tramadol, and a large number of designer analogs such as U-47700, AH-7921, and various fentanyl derivatives[4][1]. This group encompasses structurally diverse compounds, including piperidinyl, benzamide, acetamide, piperazine, and benzimidazole classes[1][4][3]. They may act as agonists or antagonists for mu, kappa, and delta opioid receptors, but "synthetic opioids" itself does not refer to any specific biological target—rather, it is the class of compounds with opioid receptor activity that are synthesized chemically[8][2][5]. The recent proliferation of new synthetic opioids is a significant public health challenge due to unpredictable potency and composition, widespread recreational use, and overdoses associated with unregulated analogs[7][5][4]. **Summary rationale:** "Synthetic opioids" is not a canonical name or abbreviation for a therapeutic target (e.g., specific receptor, enzyme, or transporter), but a broad descriptor for a chemically synthesized drug class. Detailed molecular or receptor-level information must be attributed to individual drugs (such as fentanyl or U-47700) or the opioid receptor proteins themselves (such as mu-opioid receptor), not the class term "synthetic opioids"[7][2][8].

Other names
Synthetic opioidsfentanyl analogsnon-fentanyl synthetic opioidsbenzimidazole-opioidsnitazenesdesigner opioidsnovel psychoactive opioidsnew psychoactive synthetic opioids
02

Disease associations

Other
03

Safety considerations

High risk of overdose and respiratory depression[6][7]High abuse potential and dependence[5][7]Variable potency, often much higher than morphine or heroin[6][4]Toxicity and fatality risks with illicit/counterfeit production (including unapproved and unknown analogs)[7][3]Difficult detection and identification due to structural diversity[1][4]

Beyond the preview

Go deeper on Synthetic Opioids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synthetic Opioids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call